What Does Johnson & Johnson’s Shot Mean for Our Vaccine Timeline?
This story is part of Science Friday’s coverage on the novel coronavirus, the agent of the disease COVID-19. Listen to experts discuss the spread, outbreak response, and treatment.
The U.S. now has a third COVID-19 vaccine in our arsenal, as Johnson & Johnson’s shot got emergency approval last weekend. This one is different from the Pfizer and Moderna vaccines already in use: It’s only one dose, it’s inexpensive, and it doesn’t require very cold temperatures for storage. This means rural communities might get vaccinated faster, and our timeline to possible COVID-19 herd immunity could improve.
Scaling up vaccinations will be critical as the homegrown U.S. COVID-19 variants are taking hold. Variants from California and New York are becoming more widespread, though it doesn’t seem like we’ll need to change our strategy for fighting COVID-19 yet.
Ira is joined by Umair Irfan, staff writer at Vox, to talk about these stories and other big science news of the week.
Invest in quality science journalism by making a donation to Science Friday.
Umair Irfan is a staff writer for Vox, based in Washington, DC.
The transcript for this segment is being processed. It will be posted within one week after the episode airs.